Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma. - Wikidata - awgldk - TriplyDB

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

http://www.wikidata.org/entity/Q27853378

about

CIViC database Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion.

P2860

2d19cf349778ba14c3336e7e95269baf1329c37d

P248

Q27612411-1477B69B-F154-4ED2-94E9-EA65C59F078C Q39097822-20EA1B17-1479-402D-86C7-78CA60BDB3A2 Q39411671-96506A4B-0B8F-4F81-9913-9FCF403CB13A Q55110736-649A023C-5896-4ABC-99F5-BCDC09118B9E Q55332886-1F5F0A69-1872-4CCD-97F7-3E4DD8A3F6DF

P2860

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

http://www.wikidata.org/entity/Q27853378

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@ast

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@en

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@nl

type

label

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@ast

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@en

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@nl

altLabel

Increased B4GALT1 expression a ...... lear cell renal cell carcinoma

@en

prefLabel

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@ast

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@en

Increased B4GALT1 expression a ...... ear cell renal cell carcinoma.

@nl

P1433

Q27853378-02073695-B151-4BBB-BC2C-666E5285ECA1

P1476

Q27853378-12F4AA39-D4AF-410A-9751-30998134F5CD

P2093

Q27853378-6C736E33-6ADF-40B0-BFBC-8CA5E491BEF7

Q27853378-81496207-D7D2-4097-A5EC-56AB089F268D

Q27853378-8824B668-E124-4C5E-B4F3-2698F3178D34

Q27853378-88A53EAE-E6D7-404A-9795-F829C6AD2362

Q27853378-9804B6FE-7B53-4500-9D67-69D5E2FF6128

Q27853378-B1D7DCE2-7065-4B7C-A3E7-6BD3F8CB98B9

Q27853378-D248D477-9B87-4BA6-AF34-0A4C3F84BBF2

Q27853378-ECE8C3C8-8F3D-4220-8CAC-276E3F9AD9A4

Q27853378-FD884762-31BF-43FF-A7B4-C7E8C0C9D979

P2860

Q27853378-00A748E0-F2E4-4F1A-A2FA-15AE63B4F783

Q27853378-1987991D-A221-4CBC-91CD-A49AEC9E71B6

Q27853378-234610F6-1984-40F7-9EF9-22737A43F62F

Q27853378-28C0D02E-1B25-4ABB-8676-601E08141A1C

Q27853378-32F86133-1DCB-4468-93E9-13FCB974E04B

Q27853378-3D5F3EAF-AE09-40A0-A528-EFA16EED2A13

Q27853378-4A4E22D7-F0DC-4CE1-9B72-17C798E4292A

Q27853378-78E893A9-1EC0-4F37-A802-C64E77F25448

Q27853378-7DE49100-2EF1-4BF7-BD3A-CC1EEF9E3D64

Q27853378-8C8D3D00-7FCD-458C-9628-8209D6EFCA12

P304

Q27853378-8481DD6B-0A08-439E-A95D-70C6462D4D94

P31

Q27853378-B9FC900E-FF41-4E66-B160-9172FD1F8997

P3181

Q27853378-C02BEC40-FBE0-46ED-BE3E-A724C6F8BBB5

P356

Q27853378-245F557B-D33C-4901-B060-AD82B6B21389

P407

Q27853378-CBC8D154-B788-4BDB-AFFC-6945E3B15B38

P433

Q27853378-90F9F3FE-EEEA-4DA6-93E6-DFC8408B0DFA

P478

Q27853378-DEB55EE0-B7D6-4885-85AD-7806DD6A57FE

P50

Q27853378-0B218391-887C-4FF9-8531-61D2BBA0D445

P577

Q27853378-4EE65DDC-9E60-47F3-8900-BC3C39AADAEF

P698

Q27853378-966B1D12-8CDC-4BAB-9D6C-8BB048AF990E

P932

Q27853378-027B73F8-5DA4-4EC3-8984-41E4E662420F

P3181

P356

ONCOTARGET.8737

P1433

P1476

Increased B4GALT1 expression a ...... lear cell renal cell carcinoma

@en

P2093

Dingwei Ye

http://www.w3.org/2001/XMLSchema#string

Hangcheng Fu

http://www.w3.org/2001/XMLSchema#string

Hongkai Wang

http://www.w3.org/2001/XMLSchema#string

Huimin An

http://www.w3.org/2001/XMLSchema#string

Jiejie Xu

http://www.w3.org/2001/XMLSchema#string

Qiang Fu

http://www.w3.org/2001/XMLSchema#string

Yao Zhu

http://www.w3.org/2001/XMLSchema#string

Yu Zhu

http://www.w3.org/2001/XMLSchema#string

Zewei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Sequential action of Ets-1 and Sp1 in the activation of the human beta-1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells

Tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis.

Molecular diagnosis and therapy of kidney cancer.

Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1

Update on the medical treatment of metastatic renal cell carcinoma.

Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

TNFα enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands

P304

32723-32730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4899423

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.8737

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27092876

http://www.w3.org/2001/XMLSchema#string

P932

5078046

http://www.w3.org/2001/XMLSchema#string